Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takamitsu Inoue

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Urology|December 3, 2014
Renal subcapsular fluid collection caused by penetration of a pancreatic pseudocystSoki Kashima, Takamitsu Inoue, Mitsuru Chiba, et al.
Oncotarget|June 5, 2018
Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patientsKazuyuki Numakura, Nobuhiro Fujiyama, Makoto Takahashi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2022
[Successful Re-Administration of Nivolumab in Patient with Metastatic Renal Cell Carcinoma : A Case Report]Hajime Sasagawa, Kazuyuki Numakura, Gaku Nakamura, et al.
Japanese Journal of Clinical Oncology|December 15, 2015
Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experienceEiji Kikuchi, Jun Miyazaki, Kazuyuki Yuge, et al.
Medical Oncology (Northwood, London, England)|November 2, 2017
Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysisTeppei Matsumoto, Shingo Hatakeyama, Teppei Ookubo, et al.
Clinical Genitourinary Cancer|August 17, 2019
Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective StudySakae Konishi, Shingo Hatakeyama, Kazuyuki Numakura, et al.
Clinical and Experimental Nephrology|August 28, 2016
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patientsRyutaro Ishitsuka, Jun Miyazaki, Daishi Ichioka, et al.
Japanese Journal of Clinical Oncology|June 23, 2018
Incidence and location of positive surgical margin among open, laparoscopic and robot-assisted radical prostatectomy in prostate cancer patients: a single institutional analysisAtsushi Koizumi, Shintaro Narita, Taketoshi Nara, et al.
BMC Cancer|April 16, 2020
Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancerYoshinori Matsuda, Shintaro Narita, Taketoshi Nara, et al.
BMC Cancer|March 16, 2018
A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional studyTakamitsu Inoue, Jun Miyazaki, Daishi Ichioka, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Urology|December 3, 2014
Renal subcapsular fluid collection caused by penetration of a pancreatic pseudocystSoki Kashima, Takamitsu Inoue, Mitsuru Chiba, et al.
Oncotarget|June 5, 2018
Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patientsKazuyuki Numakura, Nobuhiro Fujiyama, Makoto Takahashi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2022
[Successful Re-Administration of Nivolumab in Patient with Metastatic Renal Cell Carcinoma : A Case Report]Hajime Sasagawa, Kazuyuki Numakura, Gaku Nakamura, et al.
Japanese Journal of Clinical Oncology|December 15, 2015
Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experienceEiji Kikuchi, Jun Miyazaki, Kazuyuki Yuge, et al.
Medical Oncology (Northwood, London, England)|November 2, 2017
Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysisTeppei Matsumoto, Shingo Hatakeyama, Teppei Ookubo, et al.
Clinical Genitourinary Cancer|August 17, 2019
Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective StudySakae Konishi, Shingo Hatakeyama, Kazuyuki Numakura, et al.
Clinical and Experimental Nephrology|August 28, 2016
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patientsRyutaro Ishitsuka, Jun Miyazaki, Daishi Ichioka, et al.
Japanese Journal of Clinical Oncology|June 23, 2018
Incidence and location of positive surgical margin among open, laparoscopic and robot-assisted radical prostatectomy in prostate cancer patients: a single institutional analysisAtsushi Koizumi, Shintaro Narita, Taketoshi Nara, et al.
BMC Cancer|April 16, 2020
Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancerYoshinori Matsuda, Shintaro Narita, Taketoshi Nara, et al.
BMC Cancer|March 16, 2018
A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional studyTakamitsu Inoue, Jun Miyazaki, Daishi Ichioka, et al.
Pageof 19